Fresenius Medical Care AG & Co KGaA Annual Shareholders Meeting Transcript
Dear shareholders, it is my great pleasure to welcome you to the Annual General Meeting of Fresenius Medical Care. Our vision is to create a future worth living for our patients worldwide every day. This vision is what drives us forward.
Fresenius Medical Care is the world's leading provider of dialysis products and services. In 2018, we treated more than 330,000 patients, up 4% on 2017. We perform one dialysis treatment every 0.6 second, which means that roughly 80 people have been treated since I started speaking. We provided approximately 50 million treatments in 2018 benefiting patients in more than 3,900 dialysis clinics in approximately 50 countries around the world. This is approximately 5% more clinics than in 2017. More patients, more treatments and more clinics.
A growing number of people around the world can enjoy a better quality of life, thanks to our products and services. To fulfill our vision, we need to be able to provide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |